Related Experiment Video
Updated: Jul 25, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Risk Factors for BI/NAP1/027 Clostridioides difficile Infections and Clinical Outcomes Compared With Non-NAP1 Strains
Nandita S Mani1, John B Lynch1, Ferric C Fang1,2
1Department of Medicine, Division of Allergy & Infectious Diseases, Harborview Medical Center and School of Medicine, University of Washington, Seattle, Washington, USA.
Abstract:
We aim to describe the characteristics, risk factors, and clinical outcomes associated with NAP1 strain Clostridioides difficile infection (CDI) in this single-center, retrospective, case-control (1:1) study. We found that the NAP1 strain accounted for 19.7% of CDI, and risk factors for acquisition included residence in skilled nursing facilities, previous CDI, and proton pump inhibitor use.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Dysbiosis of the Gut Microbiota
Determinants of Bacterial Pathogenicity and Virulence
Clinical Significance of Antibiotic Resistance
Inflammatory Bowel Disease III: Crohn's Disease

